Team Blog


  • Intelligent Inhalers

    Are smarter inhalers a real possibility? David Harris looks at the barriers and the opportunities.

  • Adherence and caring

    Through an interview with a COPD patient, Martin Bontoft looks at the context of the patient’s condition and the very personal barriers to better adherence.

Similar People


Jon Jamin
Senior Mechanical Design Consultant

Read more

Jon joined Team after having been an associate mechanical designer [...]

Julia Allwright

Julia Allwright
Consultant

Read more

Julia joined the mechanical engineering group in 2014 where she [...]

Occoris-concept-being-used-

Ground-breaking inhaler engine unlocks new markets beyond asthma

Today we have released feasibility test results for our innovative Occoris® inhaler engine concept, demonstrating a significant improvement in the efficiency of drug delivery to the deep lung compared to typical dry powder inhaler (DPI) devices.
Occoris_inhaler_concept

Team Consulting receives Technology Strategy Board grant to develop ground-breaking Occoris inhaler

Team Consulting has been awarded a feasibility grant by the Technology Strategy Board, the UK’s innovation agency, to further test the commercial manufacturability of its innovative Occoris™ inhaler ‘engine’ technology. Team’s Occoris technology could potentially open up a wide range of new opportunities in the pulmonary drug delivery sector beyond the traditional asthma and COPD market.
David Harris, Principal Consultant

Polarised trends at RDD 2012

Some 600 delegates braved the heat of the Arizona desert to attend the...
prohaler_150x150

New Inhaler Delivers Simplicity with Enhanced Drug Delivery Performance

A new Dry Powder Inhaler (DPI), designed and developed by Valois Pharma with the support of Team Consulting, was presented for the first time at the recent Drug Delivery to the Lungs Conference in Edinburgh. Whilst offering excellent delivery performance, the Prohaler™ was designed from the outset with the user in mind and is completely intuitive to use.

Team and Valois Pharmaceutical Division partner on new dry powder inhaler development

Team Consulting and Valois Pharmaceutical Division today announced they have embarked upon a major development programme to produce a novel breath-actuated multi-dose Dry Powder Inhaler (DPI). The 'Bead Inhaler' will utilise a unique dispersion technology proven to deliver excellent aerosolisation performance, reproducible emitted dose and high fine particle fraction. A novel drug storage and release technology is also being developed. In addition to offering excellent delivery performance and moisture protection with a wide range of formulations, the inhaler will be compact and simple to use.